132 related articles for article (PubMed ID: 11592529)
1. Brimonidine's neuroprotective effects against transient ischaemia-induced retinal ganglion cell death.
Vidal-Sanz M; Lafuente MP; Mayor-Torroglosa S; Aguilera ME; Miralles de Imperial J; Villegas-Pérez MP
Eur J Ophthalmol; 2001; 11 Suppl 2():S36-40. PubMed ID: 11592529
[TBL] [Abstract][Full Text] [Related]
2. Retinal ganglion cell death induced by retinal ischemia. neuroprotective effects of two alpha-2 agonists.
Vidal-Sanz M; Lafuente MP; Mayor S; de Imperial JM; Villegas-Pérez MP
Surv Ophthalmol; 2001 May; 45 Suppl 3():S261-7; discussion S273-6. PubMed ID: 11377446
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of brimonidine against transient ischemia-induced retinal ganglion cell death: a dose response in vivo study.
Lafuente MP; Villegas-Pérez MP; Mayor S; Aguilera ME; Miralles de Imperial J; Vidal-Sanz M
Exp Eye Res; 2002 Feb; 74(2):181-9. PubMed ID: 11950228
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of alpha(2)-selective adrenergic agonists against ischemia-induced retinal ganglion cell death.
Lafuente MP; Villegas-Pérez MP; Sobrado-Calvo P; García-Avilés A; Miralles de Imperial J; Vidal-Sanz M
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2074-84. PubMed ID: 11481275
[TBL] [Abstract][Full Text] [Related]
5. Alpha-2 adrenergic receptor agonists are neuroprotective in experimental models of glaucoma.
Wheeler LA; Woldemussie E
Eur J Ophthalmol; 2001; 11 Suppl 2():S30-5. PubMed ID: 11592528
[TBL] [Abstract][Full Text] [Related]
6. Role of alpha-2 adrenergic receptors in neuroprotection and glaucoma.
Wheeler LA; Gil DW; WoldeMussie E
Surv Ophthalmol; 2001 May; 45 Suppl 3():S290-4; discussion S295-6. PubMed ID: 11377451
[TBL] [Abstract][Full Text] [Related]
7. From the lab to the clinic: activation of an alpha-2 agonist pathway is neuroprotective in models of retinal and optic nerve injury.
Wheeler LA; Lai R; Woldemussie E
Eur J Ophthalmol; 1999; 9 Suppl 1():S17-21. PubMed ID: 10230601
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effect of topically applied brimonidine tartrate 0.2% in endothelin-1-induced optic nerve ischaemia model.
Aktaş Z; Gürelik G; Akyürek N; Onol M; Hasanreisoğlu B
Clin Exp Ophthalmol; 2007 Aug; 35(6):527-34. PubMed ID: 17760634
[TBL] [Abstract][Full Text] [Related]
9. Transient ischemia of the retina results in altered retrograde axoplasmic transport: neuroprotection with brimonidine.
Lafuente López-Herrera MP; Mayor-Torroglosa S; Miralles de Imperial J; Villegas-Pérez MP; Vidal-Sanz M
Exp Neurol; 2002 Dec; 178(2):243-58. PubMed ID: 12504883
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of brain-derived neurotrophic factor expression by brimonidine in rat retinal ganglion cells.
Gao H; Qiao X; Cantor LB; WuDunn D
Arch Ophthalmol; 2002 Jun; 120(6):797-803. PubMed ID: 12049586
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of alpha(2) agonist (brimonidine) on adult rat retinal ganglion cells after increased intraocular pressure.
Ahmed FA; Hegazy K; Chaudhary P; Sharma SC
Brain Res; 2001 Sep; 913(2):133-9. PubMed ID: 11549376
[TBL] [Abstract][Full Text] [Related]
12. RGC death in mice after optic nerve crush injury: oxidative stress and neuroprotection.
Levkovitch-Verbin H; Harris-Cerruti C; Groner Y; Wheeler LA; Schwartz M; Yoles E
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4169-74. PubMed ID: 11095611
[TBL] [Abstract][Full Text] [Related]
13. Brimonidine blocks glutamate excitotoxicity-induced oxidative stress and preserves mitochondrial transcription factor a in ischemic retinal injury.
Lee D; Kim KY; Noh YH; Chai S; Lindsey JD; Ellisman MH; Weinreb RN; Ju WK
PLoS One; 2012; 7(10):e47098. PubMed ID: 23056591
[TBL] [Abstract][Full Text] [Related]
14. Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments.
Hernández M; Urcola JH; Vecino E
Exp Eye Res; 2008 May; 86(5):798-806. PubMed ID: 18394603
[TBL] [Abstract][Full Text] [Related]
15. The neuropeptide NAP provides neuroprotection against retinal ganglion cell damage after retinal ischemia and optic nerve crush.
Jehle T; Dimitriu C; Auer S; Knoth R; Vidal-Sanz M; Gozes I; Lagrèze WA
Graefes Arch Clin Exp Ophthalmol; 2008 Sep; 246(9):1255-63. PubMed ID: 18414890
[TBL] [Abstract][Full Text] [Related]
16. Brimonidine is neuroprotective against glutamate-induced neurotoxicity, oxidative stress, and hypoxia in purified rat retinal ganglion cells.
Lee KY; Nakayama M; Aihara M; Chen YN; Araie M
Mol Vis; 2010 Feb; 16():246-51. PubMed ID: 20161817
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of topical CB1 agonist WIN 55212-2 on retinal ganglion cells after acute rise in intraocular pressure induced ischemia in rat.
Pinar-Sueiro S; Zorrilla Hurtado JÁ; Veiga-Crespo P; Sharma SC; Vecino E
Exp Eye Res; 2013 May; 110():55-8. PubMed ID: 23454099
[TBL] [Abstract][Full Text] [Related]
18. Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity.
Dong CJ; Guo Y; Agey P; Wheeler L; Hare WA
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4515-22. PubMed ID: 18566471
[TBL] [Abstract][Full Text] [Related]
19. The growth factor response in ischemic rat retina and superior colliculus after brimonidine pre-treatment.
Lönngren U; Näpänkangas U; Lafuente M; Mayor S; Lindqvist N; Vidal-Sanz M; Hallböök F
Brain Res Bull; 2006 Dec; 71(1-3):208-18. PubMed ID: 17113948
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension.
WoldeMussie E; Ruiz G; Wijono M; Wheeler LA
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2849-55. PubMed ID: 11687528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
